Health Cor Management, L.P. Gilead Sciences, Inc. Transaction History

Health Cor Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $17.8 Million - $22.7 Million	-283,520 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $12.3 Million - $13.5 Million	-199,410 Reduced 41.29%	283,520 $18.4 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $17.5 Million - $19.3 Million	-280,370 Reduced 36.73%	482,930 $30.6 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $8.65 Million - $9.7 Million	139,810 Added 22.42%	763,300 $51.6 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $39 Million - $43.7 Million	623,490 New	623,490 $40.5 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $8.04 Million - $10.5 Million	-132,870 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $9.47 Million - $10.5 Million	132,870 New	132,870 $10.3 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $42.6 Million - $49.7 Million	-656,690 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $47.8 Million - $58.3 Million	656,690 New	656,690 $49.5 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.